Amid an obesity epidemic, these drugs hold a promise for healthier, slimmer, and more fulfilling lives for millions of Americans
Canadas Drug Agency (CDA-AMC) now recommends public coverage of Wegovy for patients with a BMI of 27 or greater and established cardiovascular disease
Understanding how that resistance develops is critical
The answer depends on your weight loss goals, medical condition, and personal preferences
Excessive production of ROS, largely arising from mitochondrial oxidative phosphorylation, is a major driver of oxidative damage and mitochondrial dysfunction processes that correlate with MDD symptom severity, illness chronicity, cognitive impairment, and poor antidepressant response [138, 139]